These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38818472)

  • 1. A Dynamic Prediction Model for Renal Progression in Primary Membranous Nephropathy.
    Liang Y; Li Q; Zou Z; Huang B; Zhong N; Li C; Wang A; Chen Y; Tu S; Wan J
    Int J Med Sci; 2024; 21(7):1292-1301. PubMed ID: 38818472
    [No Abstract]   [Full Text] [Related]  

  • 2. Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome.
    Liu L; Wang H; Zhao B; Liu X; Sun Y; Mao Y
    Int Urol Nephrol; 2022 Feb; 54(2):331-341. PubMed ID: 33909236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New risk score for predicting progression of membranous nephropathy.
    Xiaofan H; Jing X; Chenni G; Yifan W; Xialian Y; Li L; Hong R; Wen Z; Weiming W; Xiaoxia P; Jingyuan X; Nan C
    J Transl Med; 2019 Feb; 17(1):41. PubMed ID: 30736804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome.
    Duan S; Chen S; Chen C; Lu F; Pan Y; Lu Y; Li Q; Liu S; Zhang B; Mao H; Xing C; Yuan Y
    Ren Fail; 2024 Dec; 46(1):2359024. PubMed ID: 38832491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy.
    Ren W; Sun J; Zhang L; He W; Guo Z; Bian Q
    J Nephrol; 2024 May; 37(4):1051-1061. PubMed ID: 38512370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction model of renal function recovery for primary membranous nephropathy with acute kidney injury.
    Chen T; Zhou Y; Zhu J; Chen X; Pan J
    BMC Nephrol; 2022 Jul; 23(1):247. PubMed ID: 35831820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary nomogram model for predicting relapse of patients with primary membranous nephropathy.
    Li M; Wang H; Lai X; Guo D; Jiang C; Fu Z; Liu X
    Ren Fail; 2023 Dec; 45(1):2199092. PubMed ID: 37038751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study.
    Yin P; Wang J; Liang W; Zhan L; Liu Y; Lin J; Chen X; He Y; Jian H; Xie Z; Tan X; Ye Q; Huang F
    Ren Fail; 2020 Nov; 42(1):675-683. PubMed ID: 32674643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
    Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
    Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-phospholipase A2 receptor (PLA2R) antibody detected at diagnosis as a predictor for clinical remission in patients with primary membranous nephropathy: a meta-analysis.
    Liang Y; Wan J; Chen Y; Pan Y
    BMC Nephrol; 2019 Sep; 20(1):360. PubMed ID: 31533641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.
    Zhou K; Zhou J; Zhou L; Xue J; Liu B; Zhang Z; Zhang X; Cai T; Shao S; Huang B; Zhang Y; Hu Z; Wang L; Liu X
    PLoS One; 2024; 19(5):e0302100. PubMed ID: 38718066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.
    Hoxha E; Harendza S; Pinnschmidt H; Panzer U; Stahl RA
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1883-90. PubMed ID: 25267554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of pathological features of primary membranous nephropathy.
    Zhang XD; Cui Z; Zhang MF; Wang J; Zhang YM; Qu Z; Wang X; Huang J; Wang F; Meng LQ; Cheng XY; Wang SX; Liu G; Zhao MH
    BMC Nephrol; 2018 Aug; 19(1):215. PubMed ID: 30153817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.
    Yamaguchi M; Ando M; Katsuno T; Tsuboi N; Maruyama S
    Ren Fail; 2018 Nov; 40(1):435-441. PubMed ID: 30052488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.
    Gupta G; Fattah H; Ayalon R; Kidd J; Gehr T; Quintana LF; Kimball P; Sadruddin S; Massey HD; Kumar D; King AL; Beck LH
    Clin Transplant; 2016 Apr; 30(4):461-9. PubMed ID: 26854647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
    Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
    Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External Validation of the International IgA Nephropathy Prediction Tool.
    Zhang J; Huang B; Liu Z; Wang X; Xie M; Guo R; Wang Y; Yu D; Wang P; Zhu Y; Ren J
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1112-1120. PubMed ID: 32616496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases.
    Wang R; Wang M; Xia Z; Gao C; Shi Z; Fang X; Wu H; Peng Y
    J Nephrol; 2021 Apr; 34(2):589-596. PubMed ID: 32770523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.